Ratings by HSBC (Rajesh Kumar)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/3/2026 IQVIA Holdings IQV Maintain Buy
(N/A)
 
 
  Details
6/3/2026 Danaher DHR Maintain Buy
(N/A)
 
 
  Details
3/17/2026 Eli Lilly LLY Downgrade Reduce
(Hold)
985.08
(1112.21)
12.91% Details
3/10/2026 Pfizer PFE Maintain Buy
(N/A)
 
 
  Details
3/10/2026 Bristol-Myers Squibb Co. BMY Maintain Hold
(N/A)
 
 
  Details
3/10/2026 Biogen BIIB Maintain Reduce
(N/A)
 
 
  Details
12/10/2025 Biogen BIIB Downgrade Reduce
(Hold)
180.44
(197.53)
9.47% Details
12/10/2025 Abbvie ABBV Upgrade Buy
(Hold)
223.12
(232.00)
3.98% Details
12/1/2025 IQVIA Holdings IQV Maintain Buy
(N/A)
 
 
  Details
12/1/2025 Danaher DHR Maintain Buy
(N/A)
 
 
  Details
10/9/2025 IQVIA Holdings IQV Upgrade Buy
(Hold)
200.86
(165.03)
-17.84% Details
10/1/2025 Abbvie ABBV Downgrade Hold
(Buy)
231.54
(232.00)
0.2% Details
8/27/2025 Eli Lilly LLY Upgrade Hold
(Reduce)
736.03
(985.08)
33.84% Details
4/28/2025 Eli Lilly LLY Downgrade Reduce
(Buy)
859.73
(736.03)
-14.39% Details
4/28/2025 Biogen BIIB Downgrade Hold
(Buy)
119.51
(197.53)
65.28% Details
4/25/2025 IQVIA Holdings IQV Downgrade Hold
(Buy)
147.06
(200.86)
36.58% Details
12/4/2024 Novartis NVS Downgrade Reduce
(Hold)
104.56
(149.15)
42.65% Details
12/4/2024 Merck MRK Upgrade Buy
(Hold)
100.61
(115.38)
14.68% Details
12/4/2024 IQVIA Holdings IQV Maintain Buy
(N/A)
 
 
  Details
12/4/2024 Gilead Sciences GILD Maintain Hold
(N/A)
 
 
  Details
6/5/2024 Abbvie ABBV Upgrade Buy
(Hold)
160.19
(232.00)
44.83% Details
4/4/2024 UnitedHealth Group UNH Upgrade Hold
(Reduce)
459.74
(407.06)
-11.46% Details
12/18/2023 UnitedHealth Group UNH Downgrade Reduce
(Hold)
534.24
(407.06)
-23.81% Details
12/18/2023 Abbvie ABBV Downgrade Hold
(Buy)
154.88
(232.00)
49.79% Details
12/18/2023 Thermo Fisher Scientific TMO New Coverage Buy
(N/A)
521.52
(464.84)
-10.87% Details
12/18/2023 Teva Pharma TEVA New Coverage Buy
(N/A)
10.23
(32.22)
214.96% Details
12/18/2023 Danaher DHR New Coverage Hold
(N/A)
229.25
(178.56)
-22.11% Details
10/27/2023 Bristol-Myers Squibb Co. BMY Upgrade Hold
(Reduce)
56.61
(54.57)
-3.6% Details
9/15/2023 Bristol-Myers Squibb Co. BMY Maintain Reduce
(N/A)
 
 
  Details
7/14/2023 Sanofi-Aventis SNY New Coverage Buy
(N/A)
51.83
(41.55)
-19.83% Details